Experimental study of the antiatherogenesis effect of Chinese medicine angelica and its mechanisms

Clinical Hemorheology and Microcirculation

Volumn 22, Issue 4, 2000, Pages 305-310

  Zhui, Yu ^a   Jing Ping, Ou Yang ^a   Yongming, Liu ^a   Lei, Wei ^a   Shuzheng, Tu ^a   Hailu, Yang ^a   Hanqiao, Zhen ^a   Xiaohong, Yan ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Angelica; Atherosclerosis; Hemorheology; Hyperlipidemia; Rabbit; Triglyceride

Indexed keywords

ANGELICA; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; BLOOD RHEOLOGY; BLOOD VISCOSITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEMATOCRIT; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; NONHUMAN; RABBIT; THORACIC AORTA;

ANIMAL; AORTA, THORACIC; AORTIC DISEASES; ARTERIOSCLEROSIS; BLOOD VISCOSITY; CHOLESTEROL; COMPARATIVE STUDY; DIET, ATHEROGENIC; DIETARY FATS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; HEMORHEOLOGY; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL CHOLESTEROL; RABBITS; TRIGLYCERIDES;

EID: 0033779233     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. M. Carantoni, F. Abbasi, Chu. L, Y.D. Chen, G.M. Reaven, P.S. Tsao and J.P. Cooke, Adherence of mononuclear cells to endothelium in vitro is increased in patients NIDDM, Diabetes Care 20(9) (1997), 1462-1465.
2. S.G. Cheng, C.C. Li and X.X. Zhuang, Protective effects of angelica sinensis injection on myocardial ischemia/reperfusion injure in rabbits, Chinese J. Integrated Traditional & Western Medicine 15(8) (1995), 486-488.
3. A. Georgepoulos, S.D. Kafonek and I. Raikhel, Diabetic postprandial triglyceride-rich lipoproteins increase esterified cholesterol accumulation in THP-1 macrophages, Metabolism 43 (1994), 1063-1072.
4. A. Hackman, Y. Abe and W. Insull, Levels of soluble cell adhesion molecules in patients with dyslipidaemia, Circulation 93 (1996), 1334-1338.
5. T.P. Hiltunen, J.S. Luoma, T. Nikkari and Y.P. Seppo, Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions, Circulation 97 (1998), 1079-1086.
6. K. Hiramatsu, E.L. Bierman and A. Chait, Metabolism of low-density lipoprotein from patients with diabetic hypertriglyc-eridemia by cultured human skin fibroblasts, Diabetes 34 (1985), 8.
7. K. Hiramatsu and Arimori, Increased Superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes, Diabetes 37 (1988), 832-837.
8. H.L. Jiao, Y.L. Liu and L.X. Wan, Effects of L-arginine on atherosclerotic plaque area of aortae and coronary arteries in rabbits with hypercholesterolemia, Chin. J. Arterioscler. 5(3) (1997), 199-202.
9. H.A.B. Multhaupt, M.E. Gafvel, K. Kariko, H. Jin, C. Arenas-Elliott, B.I. Goldman, J.F.III. Strauss, B. Angelin, M.J. Warhol and K.R. McCrae, Expression of very low density lipoprotein receptor in the vascular wall: analysis of human tissues by in situ hybridization and immunohistochemistry, Am. J. Pathol. 148 (1996), 1985-1997.
10. L. Prónai, K. Hiramatsu and Y. Saigusa, Low Superoxide scavenging activity associated with enhanced Superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes, Atherosclerosis 90 (1991), 39-47.
11. G. Steiner, Intermediate-density lipoproteins, diabetes and coronary artery disease, Diabetes. Res. Clin. Pract. 40(Suppl.) (1998), S29-S33.
12. S. Takahashi, Y. Kawarabayasi, T. Nakai, J. Sakai and T. Yamamoto, Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor like protein with distinct ligand specificity, Proc. Natl. Acad. Sci. USA 89 (1992), 9252-9256.
13. Y.P. Wang, Pharmacological research progress of angelica sinensis, Chongqing. Med. J. 18(4) (1989), 39-41.